Vanguard Group Inc Adma Biologics, Inc. Transaction History

Vanguard Group Inc

  • $6.57 Trillion
  • Q4 2025

A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 20,854,669 shares of ADMA stock, worth $324 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,854,669
Previous 20,974,996 0.57%
Holding current value
$324 Million
Previous $307 Million 5.53%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026
SELL
$13.99 - $16.46 $1.68 Million - $1.98 Million
-120,327 Reduced 0.57%
20,854,669 $324 Million
Q3 2025

Nov 07, 2025
SELL
$14.66 - $19.91 $5.7 Million - $7.74 Million
-388,719 Reduced 1.82%
20,974,996 $307 Million
Q2 2025

Aug 11, 2025
BUY
$17.6 - $24.51 $79.6 Million - $111 Million
4,522,266 Added 26.85%
21,363,715 $389 Million
Q1 2025

May 09, 2025
SELL
$15.44 - $20.61 $21 Million - $28 Million
-1,357,347 Reduced 7.46%
16,841,449 $334 Million
Q4 2024

Feb 11, 2025
BUY
$15.62 - $22.62 $1.25 Million - $1.82 Million
80,302 Added 0.44%
18,198,796 $312 Million
Q3 2024

Nov 13, 2024
BUY
$11.21 - $20.03 $40.4 Million - $72.1 Million
3,601,842 Added 24.81%
18,118,494 $362 Million
Q2 2024

Aug 13, 2024
BUY
$5.98 - $11.18 $10.9 Million - $20.4 Million
1,827,258 Added 14.4%
14,516,652 $162 Million
Q1 2024

May 10, 2024
SELL
$4.4 - $6.74 $890,916 - $1.36 Million
-202,481 Reduced 1.57%
12,689,394 $83.8 Million
Q4 2023

Feb 14, 2024
BUY
$3.08 - $4.52 $339,354 - $498,013
110,180 Added 0.86%
12,891,875 $58.3 Million
Q3 2023

Nov 14, 2023
BUY
$3.47 - $4.61 $1.17 Million - $1.55 Million
336,190 Added 2.7%
12,781,695 $45.8 Million
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $1.98 Million - $2.67 Million
633,878 Added 5.37%
12,445,505 $45.9 Million
Q1 2023

May 15, 2023
BUY
$3.01 - $3.87 $2.81 Million - $3.61 Million
932,968 Added 8.58%
11,811,627 $39.1 Million
Q4 2022

Feb 10, 2023
BUY
$2.47 - $3.88 $3.92 Million - $6.16 Million
1,587,960 Added 17.09%
10,878,659 $42.2 Million
Q3 2022

Nov 14, 2022
BUY
$2.03 - $2.86 $508,423 - $716,301
250,455 Added 2.77%
9,290,699 $22.6 Million
Q2 2022

Aug 12, 2022
BUY
$1.43 - $2.2 $1.29 Million - $1.98 Million
901,824 Added 11.08%
9,040,244 $17.9 Million
Q1 2022

May 13, 2022
SELL
$1.28 - $1.83 $442,419 - $632,521
-345,640 Reduced 4.07%
8,138,420 $14.9 Million
Q4 2021

Feb 14, 2022
BUY
$1.09 - $1.66 $3.01 Million - $4.58 Million
2,760,709 Added 48.24%
8,484,060 $12 Million
Q3 2021

Nov 12, 2021
BUY
$1.13 - $1.65 $128,968 - $188,316
114,131 Added 2.03%
5,723,351 $6.47 Million
Q2 2021

Aug 13, 2021
BUY
$1.51 - $2.07 $8.47 Million - $11.6 Million
5,609,220 New
5,609,220 $8.98 Million

Others Institutions Holding ADMA

# of Institutions
409
Shares Held
204M
Call Options Held
3.06M
Put Options Held
1.88M
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email